A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder

12Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Open-label quetiapine coadministration with SSRI therapy, in a diagnostically mixed sample of comorbid anxiety patients, offered additional anxiolytic benefit. Therefore, we designed the following controlled trial to confirm these findings in a comorbid, SSRI-resistant, panic disorder (PD) patient sample. Methods: This was a single-site, double-blind, placebo-controlled (PLAC), randomized, parallel group (2 groups), 8-week, quetiapine extended release (XR) coadministration trial. SSRI resistance was determined either historically or prospectively. Patients were randomized if they remained moderately ill (CGI-S score≥4). Change in the PDSS scale total score was the primary efficacy outcome measure. Responders were identified as those with a≥50% decrease from their baseline PDSS score. In the early weeks of therapy, XR was flexibly and gradually titrated from 50 to 400mg/day. Results: 43 patients were screened in total, and 26 of these were randomized and evaluable. 21 patients (78% of the randomized group) completed the trial (10 XR; 11 PLAC). The endpoint quetiapine XR mean daily dose±SD was 150±106mg. While, in the sample as a whole, there was improvement in PDSS scores across the 8-week trial (ANOVA main effect of time, F=10.9, df 8,192, p<0.0001), the treatment × time interaction effect was not statistically significant (F=0.8, df 8,192, p=0.61). There was no between-group difference in responder frequency at endpoint. Conclusions: This proof-of-concept RCT did not support the efficacy of this treatment strategy for SSRI-resistant PD. Quetiapine XR was generally well-tolerated. Important limitations were the small sample size, and the relatively low average dose of quetiapine XR used. ClinicalTrials.gov ID#: NCT00619892

Cite

CITATION STYLE

APA

Goddard, A. W., Mahmud, W., Medlock, C., Shin, Y. W., & Shekhar, A. (2015). A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder. Annals of General Psychiatry, 14(1). https://doi.org/10.1186/s12991-015-0064-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free